
May 17, 2016 Manufacturing and Production, Sales and Marketing Allergan, FDA, chronic eye disease

May 17, 2016 Manufacturing and Production, Research and Development AstraZeneca, asthma drug, benralizumab, drug trial

May 17, 2016 Manufacturing and Production, Sales and Marketing Isuprel, Nitropress, Valeant, discounts

May 17, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets

May 16, 2016 Manufacturing and Production, Sales and Marketing 5.2 billion, FDA, Pfizer, acquisition, anacor, crisaborole, merger

May 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Medivation, Sanofi, replace board, takeover

May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe

May 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ariad, Incyte, Operations, buy out, european, iclusig, leukaemia, out-license

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

May 10, 2016 Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio
May 10, 2016 Manufacturing and Production, Research and Development Kalydeco, Orkambi, SMC, Vertex Pharma, cystic fibrosis, regulation

May 10, 2016 Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay